Jump to Main Contents

先端医療開発センター

News

Mar. 28, 2025
New Radiopharmaceuticals for Renal Cell Carcinoma
Mar. 10, 2025
Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
Feb. 21, 2025
Thai FDA Officials Visited NCC Kashiwa Campus for Training Program
Oct. 21, 2024
EPOC Researchers catalog has been update
Jun. 21, 2024
Division of Innovative Pathology and Laboratory Medicine(Kashiwa) Publications list has been updated
More
:トップ画像
:トップ画像

Inquire About collaborative Research

  1. We will promote collaborative research with the outside more in future.
  2. If you would like to inquire about our research, please contact the following contact.
  3. Your inquiries will be accepted at the secretariat of EPOC. It will be anonymized as necessary.

Secretariat of EPOC

Inquire About Collaborative Research

グループ紹介

Group for Clinical Research

Division of Experimental Therapeutics

 

Group for Translational Research

Division of Biomarker Discovery

 

Division of Translational Genomics

 

Division of Innovative Pathology and Laboratory Medicine

 

Division of Clinical Pharmacology and Translational Research

 

Division of Cancer Immunology

 

Division of Translational Informatics

 

Group for Innovative Cancer Treatment

Division of Cancer Immunotherapy

 

Division of Supportive Care Research

 

Division of Psycho-Oncology

 

Division of Pathology

 

Division of Developmental Therapeutics

 

Group for Innovative Diagnostic and Therapeutic Device

Division of Science and Technology for Endoscopy

 

Division of Surgical Technology

 

Division of Boron Neutron Capture Therapy

 

Division of Radiation Oncology and Particle Therapy

 

Division of Functional Imaging

 

Core Facilities

Section of Support of Animal Experimentation

 

Section of Experimental Animals

 

Department of Strategic Programs

 

Division of Collaborative Research and Developments

 

Research Project

Project for Supportive Care Research

 

  • This is a succeeded project that focuses on the theme of advancing translational research conducted in the Division of Supportive Care Research at EPOC since 2015. The aim is to develop unmet medical needs for cancer patients, such as novel analgesics that contribute to improve the quality of life (QOL) of cancer patients and drugs that improve cancer cachexia symptoms, with pharmaceutical companies. In collaboration with the Support and Palliative Development Research Support Office established at the National Cancer Center Hospital East in April 2020, we conduct translational research with developed preclinical seeds and compounds and convey them stages of Phase I or Phase II trials. Accordingly, we will innovate novel drugs that contribute to the improvement of supportive and palliative care in the clinical fields.
  • Kashiwa
Project for Prevention of HPV-related cancer

 

Superhuman Medical Care Project